Detalles de la búsqueda
1.
Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
J Virol
; 93(7)2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674625
2.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
J Virol
; 92(8)2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437967
3.
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
J Virol
; 89(7): 3819-32, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25609807
4.
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
J Virol
; 89(12): 6462-80, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25855741
5.
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
J Antimicrob Chemother
; 70(6): 1833-42, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724985
6.
Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.
J Virol
; 88(6): 3392-410, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390336
7.
Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection.
PLoS Pathog
; 9(11): e1003719, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24244156
8.
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
J Immunol
; 190(6): 2720-35, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23390298
9.
High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.
J Virol
; 87(13): 7282-300, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23596307
10.
Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.
J Immunol
; 188(12): 6407-17, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22615208
11.
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
Proc Natl Acad Sci U S A
; 108(17): 7131-6, 2011 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21467219
12.
Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.
J Immunol
; 185(11): 7097-106, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21041730
13.
Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.
Front Immunol
; 13: 939627, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35935978
14.
Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.
J Virol
; 84(16): 8141-52, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20534857
15.
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
PLoS Pathog
; 5(6): e1000480, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19543380
16.
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.
Proc Natl Acad Sci U S A
; 105(6): 2046-51, 2008 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18270165
17.
Neutrophil subtypes shape HIV-specific CD8 T-cell responses after vaccinia virus infection.
NPJ Vaccines
; 6(1): 52, 2021 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33846352
18.
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B.
Vaccines (Basel)
; 8(1)2020 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32041218
19.
Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV.
Vaccines (Basel)
; 8(3)2020 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32764419
20.
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.
Front Immunol
; 11: 586124, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33244316